| | | | | | | | | | |
|
|
| Dockets Entered
On April 26, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
| 1983V-0151
|
| LASER LIGHT SHOW
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| 2000P-1602
|
| Remove Unapproved Children's Fluoride Supplements from Mkt
|
|
|
| 2003D-0044
|
| Reporting Results for Studies Evaluating Diagnostic Tests
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing, and Handling of Food
|
|
|
| 2005N-0279
|
| Food Labeling; Gluten-Free Labeling of Foods
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2006D-0480
|
| Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
| 2006P-0405
|
| Require full prescribing information of all antiepileptic drugs contain specific language under Warnings or Warnings and Precautions
|
|
|
| 2006P-0428
|
| Combivent (ipratropium bromide and albuterol sulfate)
|
|
|
| 2006P-0442
|
| Determine that Wyeth Pharmaceuticals, Inc. discontinued its previously-approved formulation of the Reference Listed Drug Zosyn (piperacillin and tazobactam for injection), 40.5 gram pharmacy bulk via
|
|
|
|
|
|
| 2006P-0445
|
| Determine if Mivacron (mivacurium chloride injection) was withdrawn for safety or efficacy reasons
|
|
|
| 2006P-0446
|
| ANDA for PHENERGAN Promethazine Hydrochloride Suppositories USP, 12.5 mg and 25 mg
|
|
|
| 2006P-0450
|
| Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
|
|
|
| 2007A-0164
|
| Request for Advisory Opinion for an Mobilecare Monitor System 2100
|
|
|
| 2007N-0051
|
| Safety of Fresh Produce; Public Hearings
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
| 2007P-0070
|
| Make fluoride a prescription drug for use in tooth application, tooth paste, and in bottled water
|
|
|
| 1978N-0038
|
| Sunscreen Drug Products
|
|
|
| C 613
|
| Premiere Center for Cosmetic Surgery
|
| Vol #:
|
| 150
|
|
|
| C 614
|
| Hillsborough County Florida
|
| Vol #:
|
| 150
|
|
|
| C 615
|
| State of New York, Albany
|
| Vol #:
|
| 150
|
|
|
| 1983V-0151
|
| LASER LIGHT SHOW
|
|
|
| VRA 11
|
| FDA/CDRH to Precision Projection Systems, Inc
|
| Vol #:
|
| 1
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| SUP 51
|
| Immediate Trial, INC 70376, Milwaukee, Wisconsin
|
| Vol #:
|
| 56
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| RPT 376
|
| Louis Montgomery Enterprises
|
| Vol #:
|
| 297
|
|
|
| 2000P-1602
|
| Remove Unapproved Children's Fluoride Supplements from Mkt
|
|
| | | | | | | | |
|
|
| LET 3
|
| FDA/CDER to J Kelly
|
| Vol #:
|
| 1
|
|
|
| LET 4
|
| FDA/CDER to J Kelly
|
| Vol #:
|
| 1
|
|
|
| 2003D-0044
|
| Reporting Results for Studies Evaluating Diagnostic Tests
|
|
|
| EC 5
|
| DHL
|
| Vol #:
|
| 1
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing, and Handling of Food
|
|
|
| C 15
|
| J. Resnick
|
| Vol #:
|
| 1
|
|
|
| C 16
|
| M. & G. Krieger
|
| Vol #:
|
| 1
|
|
|
| 2005N-0279
|
| Food Labeling; Gluten-Free Labeling of Foods
|
|
|
| C 721
|
| Food Marketing Institute
|
| Vol #:
|
| 35
|
|
|
| C 722
|
| U. S. A. Rice Federation
|
| Vol #:
|
| 35
|
|
|
| C 723
|
| Food Products Association
|
| Vol #:
|
| 35
|
|
|
| C 724
|
| L. Block
|
| Vol #:
|
| 35
|
|
|
| C 725
|
| Glutino U. S. A.
|
| Vol #:
|
| 35
|
|
|
| C 726
|
| International Wheat Gluten Association
|
| Vol #:
|
| 35
|
|
|
| C 727
|
| International Wheat Gluten Association
|
| Vol #:
|
| 35
|
|
|
| C 728
|
| Coastal Counseling Clinic
|
| Vol #:
|
| 35
|
|
|
| C 729
|
| The Vinegar Institute
|
| Vol #:
|
| 35
|
|
|
| C 730
|
| Association des Amldenniers et Foculiers
|
| Vol #:
|
| 35
|
|
|
| C 731
|
| Celiac Sprue Association U. S. A., Inc.
|
| Vol #:
|
| 35
|
|
|
| C 732
|
| T. Sullivan
|
| Vol #:
|
| 35
|
|
|
| C 733
|
| S. Tolley
|
| Vol #:
|
| 35
|
|
|
| C 734
|
| China SPS Enquiry Point, AQSIQ
|
| Vol #:
|
| 35
|
|
|
| C 735
|
| F. Tibbits
|
| Vol #:
|
| 35
|
|
|
| C 736
|
| C. Adams
|
| Vol #:
|
| 35
|
|
|
| C 737
|
| International Wheat Gluten Association
|
| Vol #:
|
| 35
|
|
|
| EC 1962
|
| Mrs. Nadine Marx
|
| Vol #:
|
| 31
|
|
|
| EC 1963
|
| Mrs. Laurie Anderson
|
| Vol #:
|
| 31
|
|
|
| EC 1964
|
| Ms. Amber Brenzikofer
|
| Vol #:
|
| 31
|
|
|
| EC 1965
|
| Ms. Huberta Yaron
|
| Vol #:
|
| 31
|
|
|
| EC 1966
|
| Ms. Jerilyn Ingram
|
| Vol #:
|
| 31
|
|
|
| EC 1967
|
| Mrs. PATRICIA KACZMAREK
|
| Vol #:
|
| 31
|
|
|
| EC 1968
|
| Dr. Joan Chase
|
| Vol #:
|
| 31
|
|
|
| EC 1969
|
| Healthy Villi-CSA/USA
|
| Vol #:
|
| 31
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
| | | | | | | | |
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
| C 87
|
| G. Schumacher
|
| Vol #:
|
| 7
|
|
|
| C 88
|
| Little Art Theatre
|
| Vol #:
|
| 7
|
|
|
| 2006P-0405
|
| Require full prescribing information of all antiepileptic drugs contain specific language under Warnings or Warnings and Precautions
|
|
|
| C 2
|
| Minnesota House of Representatives
|
| Vol #:
|
| 2
|
|
|
| 2006P-0428
|
| Combivent (ipratropium bromide and albuterol sulfate)
|
|
|
| LET 1
|
| FDA/CDER to Boehringer Ingelheim Pharmaceuticalws Inc
|
| Vol #:
|
| 2
|
|
|
| 2006P-0442
|
| Determine that Wyeth Pharmaceuticals, Inc. discontinued its previously-approved formulation of the Reference Listed Drug Zosyn (piperacillin and tazobactam for injection), 40.5 gram pharmacy bulk via
|
|
|
|
| |
|
| LET 1
|
| FDA/CDER to Orchid Healthcare
|
| Vol #:
|
| 1
|
|
|
| 2006P-0445
|
| Determine if Mivacron (mivacurium chloride injection) was withdrawn for safety or efficacy reasons
|
|
|
| LET 1
|
| FDA/CDER to Regulus Pharmaceutical Consulting Inc
|
| Vol #:
|
| 1
|
|
|
| 2006P-0446
|
| ANDA for PHENERGAN Promethazine Hydrochloride Suppositories USP, 12.5 mg and 25 mg
|
|
|
| LET 1
|
| FDA/Taro Pharmaceuticals USA Inc
|
| Vol #:
|
| 1
|
|
|
| 2006P-0450
|
| Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
|
|
|
| LET 1
|
| FDA/CDER to Pfizer Inc
|
| Vol #:
|
| 2
|
|
|
| 2007A-0164
|
| Request for Advisory Opinion for an Mobilecare Monitor System 2100
|
|
|
| ACK 1
|
| FDA/DDM to AFrame Digital, Inc
|
| Vol #:
|
| 1
|
|
|
| AP 1
|
| AFrame Digital, Inc
|
| Vol #:
|
| 1
|
|
|
| 2007N-0051
|
| Safety of Fresh Produce; Public Hearings
|
|
|
| C 7
|
| L-3 Pulse Sciences
|
| Vol #:
|
| 1
|
|
|
| C 8
|
| Path Trace
|
| Vol #:
|
| 1
|
|
|
| TS 1
|
| Centers for Disease Control and Prevention
|
| Vol #:
|
| 1
|
|
|
| TS 2
|
| Cemter for Food Safety and Applied Nutrition
|
| Vol #:
|
| 1
|
|
|
| TS 3
|
| University of California, Davis
|
| Vol #:
|
| 1
|
|
|
| TS 4
|
| FDA/ Center for Food Sfaety and Applied Nutrition
|
| Vol #:
|
| 1
|
|
|
| TS 5
|
| FDA/ Office of Regulatory Affairs
|
| Vol #:
|
| 1
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
| EAPE 109
|
| Evelyn, Brenda
|
| Vol #:
|
| 1
|
|
|
| 2007P-0070
|
| Make fluoride a prescription drug for use in tooth application, tooth paste, and in bottled water
|
|
|
| C 1
|
| C. Weber
|
| Vol #:
|
| 1
|
|